Identification

Ticker
OCTO
Codice ISIN
NL0000345718
Mercato
Euronext
Borsa
Amsterdam
Products family
Stocks
Market organization
Euronext-LocalSecurities
ICB
Biotechnology
Activity description

OctoPlus is a drug delivery company specialized in the development of improved pharmaceutical products that are based on OctoPlus' proprietary drug delivery technologies and have fewer side effects, improved patient convenience and a better efficacy/safety balance than existing therapies. In addition, the group is a leading European provider of advanced drug formulation and clinical scale manufacturing services to the pharmaceutical and biotechnology industries, with a focus on difficult-to-formulate active pharmaceutical ingredients.

  • Net sales break down by source of income as follows: sales of services (97.9%), licensing revenues (1.9%) and subsidies (0.2%).
  • Net sales are distributed geographically as follows: Europe (28.6%), North America (60.6%) and other (10.8%).
Indirizzo web
www.octoplus.nl
Indirizzo web
www.octoplus.nl

Operation

Data IPO
Ven 22/05/2009
Tipologia IPO
Initial Public offering
New Issue Special Session
Categoria
New Issue Special Session
Procedura

OFFER SHARES